The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling and clinical characteristic of malignant melanoma in younger patients.
 
Jomjit Chantharasamee
No Relationships to Disclose
 
Karlton Wong
No Relationships to Disclose
 
Bartosz Chmielowski
Consulting or Advisory Role - Array BioPharma; Biothera; Compugen; Deciphera; Epizyme; HUYA Bioscience International; IDEAYA Biosciences; Iovance Biotherapeutics; Janssen; Regeneron
Speakers' Bureau - Janssen Oncology; Sanofi/Regeneron
Research Funding - Advenchen Laboratories (Inst); Aeglea Biotherapeutics (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Biothera (Inst); Bristol-Myers Squibb (Inst); Compugen (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Idera (Inst); Immunocore (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Iovance Biotherapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly/ImClone (Inst); Macrogenics (Inst); Merck (Inst); Neon Therapeutics (Inst); PACT Pharma (Inst); RAPT Therapeutics (Inst); Rgenix (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Compugen; Deciphera; Epizyme; HUYA Bioscience International; IDEAYA Biosciences; Iovance Biotherapeutics; Regeneron